Jeremy Katzen

Pulmonary Fibrosis Foundation scientist wins NIH award

Merck Oncolmmune

Merck to buy OncoImmune and its potential COVID treatment for $425M

HHS confirms involvement in presidential transition process


Who should get COVID-19 vaccines first? CDC advisors have ideas

Who would — and wouldn’t — line up for COVID-19 vaccines?

Regeneron antibody cocktail wins emergency use authorization

DNA genotyping and sequencing

How COVID-19 has affected Big Pharma and biotech

Coronavirus vaccine

How U.S. government bolstered Moderna’s COVID-19 vaccine candidate

BREAKING: AstraZeneca says its COVID vaccine up to 90% effective